Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy.
Molecular therapy : the journal of the American Society of Gene Therapy | 2014-01-01 | PMID 24343053
Workenhe Samuel T, Simmons Graydon, Pol Jonathan G and 3 more
